Action of fluconazole (UK-49, 858) in relation to other systemic antifungal azoles
- 1 February 1987
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 19 (2) , 171-174
- https://doi.org/10.1093/jac/19.2.171
Abstract
Viability studies showed that fluconazole (UK-49,858) was strictly fungistatic in its activity against three strains of Candida species, whether tested against yeasts in stationary or early logarithmic phase. In this regard, fluconazole appears to offer no advantage over three other oral azole-containing agents, including ketoconazole, vibunazole (Bay n 7133), and ICI 153,066.Keywords
This publication has 7 references indexed in Scilit:
- Comparison of itraconazole and fluconazole in treatment of cryptococcal meningitis and candida pyelonephritis in rabbitsAntimicrobial Agents and Chemotherapy, 1986
- Comparative activities of UK-49,858 and amphotericin B against Blastomyces dermatitidis infections in miceAntimicrobial Agents and Chemotherapy, 1986
- Efficacy of UK-49,858 (fluconazole) against Candida albicans experimental infections in miceAntimicrobial Agents and Chemotherapy, 1985
- Pharmacokinetic evaluation of UK-49,858, a metabolically stable triazole antifungal drug, in animals and humansAntimicrobial Agents and Chemotherapy, 1985
- Activity of UK-49,858, a bis-triazole derivative, against experimental infections with Candida albicans and Trichophyton mentagrophytesAntimicrobial Agents and Chemotherapy, 1985
- Growth phase in relation to ketoconazole and miconazole susceptibilities of Candida albicansAntimicrobial Agents and Chemotherapy, 1984
- Heterogeneity of action of mechanisms among antimycotic imidazolesAntimicrobial Agents and Chemotherapy, 1981